As of 18 Sept 2026, Accretion Pharmaceuticals Ltd share price is ₹210.85. The stock opened at ₹210.85 and had closed at ₹208.80 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹53.80 and a high of ₹219.00. In terms of performance, Accretion Pharmaceuticals Ltd share price has increased by 220.98% over the past six months and has increased by 221.97% over the last year.
ACCPL Stock Price Chart
Accretion Pharmaceuticals Ltd Overview
About ACCPL
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Our business is majorly carried out on principal-to-principal basis with different marketers. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis.
Accretion Pharmaceuticals Ltd Historical Performance
Accretion Pharmaceuticals Ltd Fundamentals
Accretion Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 89.82 | 57.47 | 13.40 | 29.53 | 22.58 |
| EBITDA | 15.14 | 11.97 | 2.62 | 2.14 | 1.93 |
| Net Profit | 9.67 | 6.79 | 1.49 | 0.10 | 0.08 |
| EPS | 9.03 | 8.48 | 1.96 | 0.27 | 0.25 |
Accretion Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 207.57 |
| Resistance 1 (R1) | 210.52 |
| Pivot Point | 209.28 |
ACCPL Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Mayur Popatlal Sojitra | Executive Directorector |
| Harshad Nanubhai Rathod | Chairman |
| Vivek Ashok Kumar Patel | Managing Director |
Accretion Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,860.80+0.39% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,315.00+1.71% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,861.00+1.01% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Accretion Pharmaceuticals Ltd today is ₹210.85 on NSE and ₹210.85 on BSE.
- The 52-week high of Accretion Pharmaceuticals Ltd is ₹219.00, while the 52-week low is ₹53.80.
- The current market capitalisation of Accretion Pharmaceuticals Ltd is approximately ₹232 crore.
- The P/E (Price-to-Earnings) ratio of Accretion Pharmaceuticals Ltd is 24.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Accretion Pharmaceuticals Ltd is 4.24. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Accretion Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ACCPL on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Accretion Pharmaceuticals Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Accretion Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 73.52% promoters, 0.00% FIIs, 2.76% DIIs, and 20.22% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
